Zhang et al. [14] have shown that when highly metastatic mouse Lewis lung carcinoma cells were treated with MβCD, their invasive capacity was suppressed and MMP-9 activity in the lipid rafts was inhibited. The gene discussed is MMP9; the disease is Carcinoma, Lewis Lung.